OncologyOnline.net

Oncology Xagena

Xagena Mappa
Medical Meeting
Cardiobase
Reumabase.it

Search results for "Pembrolizumab plus Axitinib"

The pivotal phase 3 KEYNOTE-426 trial investigating Pembrolizumab ( Keytruda ), an anti-PD-1 therapy, in combination with Axitinib ( Inlyta ), tyrosine kinase inhibitor, met both primary endpoints of ...